These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33318426)

  • 1. The effects of amyloid-beta on hippocampal glutamatergic receptor and transporter expression.
    Kwakowsky A; Waldvogel HJ; Faull RL
    Neural Regen Res; 2021 Jul; 16(7):1399-1401. PubMed ID: 33318426
    [No Abstract]   [Full Text] [Related]  

  • 2. The Acute Effects of Amyloid-Beta
    Yeung JHY; Palpagama TH; Tate WP; Peppercorn K; Waldvogel HJ; Faull RLM; Kwakowsky A
    Front Neurosci; 2019; 13():1427. PubMed ID: 32009891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-beta
    Yeung JHY; Calvo-Flores Guzmán B; Palpagama TH; Ethiraj J; Zhai Y; Tate WP; Peppercorn K; Waldvogel HJ; Faull RLM; Kwakowsky A
    J Neurochem; 2020 Oct; 155(1):62-80. PubMed ID: 32491248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal Cholinergic Neurostimulating Peptide as a Possible Modulating Factor against Glutamatergic Neuronal Disability by Amyloid Oligomers.
    Sato T; Ohi Y; Kato D; Mizuno M; Takase H; Kanamori T; Borlongan CV; Haji A; Matsukawa N
    Cell Transplant; 2017 Sep; 26(9):1542-1550. PubMed ID: 29113468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate receptor and transporter modifications in rat organotypic hippocampal slice cultures exposed to oxygen-glucose deprivation: the contribution of cyclooxygenase-2.
    Llorente IL; Landucci E; Pellegrini-Giampietro DE; Fernández-López A
    Neuroscience; 2015 Apr; 292():118-28. PubMed ID: 25732138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells.
    Lee HJ; Lee JO; Lee YW; Kim SA; Seo IH; Han JA; Kang MJ; Kim SJ; Cho YH; Park JJ; Choi JI; Park SH; Kim HS
    Int J Neuropsychopharmacol; 2019 Jun; 22(6):402-414. PubMed ID: 31125414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hippocampal neuronal cell death induction after acute and repeated paraquat exposures mediated by AChE variants alteration and cholinergic and glutamatergic transmission disruption.
    Del Pino J; Moyano P; Díaz GG; Anadon MJ; Diaz MJ; García JM; Lobo M; Pelayo A; Sola E; Frejo MT
    Toxicology; 2017 Sep; 390():88-99. PubMed ID: 28916328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ß-amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices.
    Kabogo D; Rauw G; Amritraj A; Baker G; Kar S
    Neurobiol Aging; 2010 Jul; 31(7):1164-72. PubMed ID: 18819729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease.
    Amorim JA; Canas PM; Tomé AR; Rolo AP; Agostinho P; Palmeira CM; Cunha RA
    J Alzheimers Dis; 2017; 60(2):525-536. PubMed ID: 28869472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease.
    Rodriguez-Perdigon M; Tordera RM; Gil-Bea FJ; Gerenu G; Ramirez MJ; Solas M
    Hippocampus; 2016 Oct; 26(10):1303-12. PubMed ID: 27258819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased ATP-binding cassette transporter A1 expression in Alzheimer's disease hippocampal neurons.
    Kim WS; Bhatia S; Elliott DA; Agholme L; Kågedal K; McCann H; Halliday GM; Barnham KJ; Garner B
    J Alzheimers Dis; 2010; 21(1):193-205. PubMed ID: 20413849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein inhibits amyloid peptide 25-35-induced neuronal death by modulating estrogen receptors, choline acetyltransferase and glutamate receptors.
    Wang YX; Xia ZH; Jiang X; Li LX; Wang HG; An D; Liu YQ
    Arch Biochem Biophys; 2020 Oct; 693():108561. PubMed ID: 32857999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging and amyloid β oligomers enhance TLR4 expression, LPS-induced Ca
    Calvo-Rodríguez M; de la Fuente C; García-Durillo M; García-Rodríguez C; Villalobos C; Núñez L
    J Neuroinflammation; 2017 Jan; 14(1):24. PubMed ID: 28143556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease.
    Canas PM; Simões AP; Rodrigues RJ; Cunha RA
    Neuropharmacology; 2014 Jan; 76 Pt A():51-6. PubMed ID: 24029236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice.
    Hooijmans CR; Graven C; Dederen PJ; Tanila H; van Groen T; Kiliaan AJ
    Brain Res; 2007 Nov; 1181():93-103. PubMed ID: 17916337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
    Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
    J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta amyloid suppresses the expression of the vitamin d receptor gene and induces the expression of the vitamin d catabolic enzyme gene in hippocampal neurons.
    Dursun E; Gezen-Ak D; Yilmazer S
    Dement Geriatr Cogn Disord; 2013; 36(1-2):76-86. PubMed ID: 23752060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.